Tobacco

British American Tobacco

British American Tobacco Repurchases 592,630 Ordinary Shares for £27.67 Million

Citi Analyst Reaffirms Buy Rating on British American Tobacco with 52 GBP Target Price

US Bank Securities Reiterates Buy Rating on British American Tobacco with Target Price of 5300 Pence

U.S. Judge Dismisses BAT Sanctions Case

British American Tobacco Announces Trieste Factory Operates on Renewable Power

British American Tobacco's Stock Price Falls Due to Conservative Financial Guidance and Regulatory Uncertainty

British American Tobacco Expresses Confidence in Midterm Goals

British American Tobacco to Hold 2026 Annual General Meeting

JPMorgan Analyst Maintains Hold Rating on British American Tobacco

British American Tobacco Repurchases 101,204 Ordinary Shares

BAT Faces Shareholder Lawsuit Over North Korea Operations

British Tobacco Reiterates 2026 Fiscal Year Guidance

Citigroup Analyst Reiterates Buy Rating on British American Tobacco

Kepler Capital Maintains Buy Rating on British American Tobacco with a Target Price of 4900 Pounds

British American Tobacco released FY2025 Annual Earnings on February 12 (EST), actual revenue USD 34.31 B (forecast USD 34.51 B), actual EPS USD 4.6765 (forecast USD 4.512)

British American Tobacco released FY2025 9 Months Earnings on February 12, 2026 (EST), with actual revenue of USD 25.18 B and EPS of USD 3.6895

British American Tobacco released FY2025 Q3 earnings on February 12, 2026 (EST) with actual revenue USD 0 and actual EPS USD 0

British American Tobacco released FY2025 Q4 earnings on February 12 (EST), actual revenue USD 9.116 B, actual EPS USD 0.9784

British American Tobacco Downgrades 2026 Revenue and Profit Growth Forecasts

British American Tobacco Plans Productivity Boost, May Lead to Layoffs

Amesite

InMed Pharmaceuticals

Meiwu Tech

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

NextNRG

CN Energy

Generation Income Properties

MetaVia

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Co-Diagnostics

BATS

FENI

The Fidelity Enhanced International ETF (FENI) has seen a notable inflow of approximately $311.7 million, marking a 3.4% increase in outstanding units week-over-week. Key components include British American Tobacco (BTI) down 1%, AerCap Holdings (AER) down 1.6%, and GSK (GSK) up 1.1%. FENI's 52-week range is $31.80 to $40.90, with the last trade at $39.09.

nasdaq

British American Tobacco p.l.c.

GlaxoSmithKline plc

Aercap Holdings NV

Fidelity Enhanced International ETF

Nasdaq

General Motors

GSK plc Sponsored ADR

Notable ETF Inflow Detected - FENI, BTI, AER, GSK

Citi analyst Simon Hales has reaffirmed a Buy rating on British American Tobacco (BATS) with a price target of £52.00. Hales, who specializes in the Consumer Defensive sector, has an average return of 3.7% and a 55.06% success rate on his stock recommendations. The overall analyst consensus for British American Tobacco is a Moderate Buy, with an average price target of £48.18.

Tip Ranks

Citigroup

Diageo plc

Diageo

Altria

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Citi Remains a Buy on British American Tobacco (BATS)

VICE

Bank of America Securities analyst Bastien Agaud has reiterated a Buy rating on British American Tobacco, setting a price target of 5,300p. This decision is based on strong U.S. growth prospects, margin improvements, and reduced regulatory risks. Agaud highlights the potential for increased earnings from modern oral products and a favorable outlook despite softer trends in other regions. He notes that the stock is undervalued compared to the European staples sector, with a higher DCF-based price target indicating significant upside potential.

- Analyst Bastian Agod from Bank of America maintains a buy rating for British American Tobacco, setting a target price of £5,300.  
- His positive outlook is driven by strong growth potential in U.S. oral products and supportive trends for combustible and vapor products due to stricter regulations on illegal vaping.  
- Despite some regional weaknesses, overall sales are expected to grow, with upward revisions in earnings per share for 2026 and 2027, suggesting significant upside potential for the stock.

AdvisorShares Vice - ETF

Analyst Reiterates Buy as U.S. Growth, Margin Upside and Lower Regulatory Risk Drive DCF-Based Price Target Increase to 5,300p

British American Tobacco p.l.c.'s stock price target has been raised to GBX 4840.91, indicating a potential upside of 4%. This adjustment comes from estimates by 11 analysts, with price forecasts ranging from GBX 3600 to GBX 5300. The consensus rating remains a 'Buy' from 13 analysts, comprising 9 Buys, 3 Holds, and 1 Sell.

TradingView

Factset Research

British American Tobacco p.l.c. Stock 12‑Month Price Target Raised to GBX 4840.91, Implies 4% Upside

ANET

SONY

QCOM

INTC

SNDK

British American Tobacco(BTI) rose 5.29%, with a trading turnover 469.2 Million USD, and a year-to-date rose 14%. Arista Networks(ANET) rose 4.48%, with a trading turnover 1.8 Billion USD, and a year-to-date rose 8.8%. Qualcomm(QCOM) fell 11.46%, with a trading turnover 8.2 Billion USD, and a year-to-date rose 23.7%. Intel(INTC) fell 6.82%, with a trading turnover 20.5 Billion USD, and a year-to-date rose 226.9%.

- The Nasdaq Composite Index fell by 0.71%, with a year-to-date increase of 12.2%.  
- The S&P 500 Index decreased by 0.16%, up 8.1% for the year, while the Dow Jones rose by 0.11% with a year-to-date gain of 3.5%.  
- Notable stock movements include British American Tobacco rising 5.29% and Qualcomm dropping 11.46%.

Top Gainers&Losers

Arista Networks

Amphenol

Stryker

Sony

Qualcomm

Intel

Sandisk

Western Digital

Corning

Top 5 US Stock Gainers/Losers (>100B) (5.12)

Tadeu Marroco, an insider at British American Tobacco (LON:BATS), purchased 36 shares at an average price of GBX 4,297 each on May 7th, totaling £1,546.92. He also made additional purchases of 6,036 shares at GBX 4,426 and 371 shares at GBX 4,286 on May 8th. The stock recently traded down 0.4% to GBX 4,267. Analysts have a consensus rating of "Hold" for the stock, with a target price of GBX 4,500. British American Tobacco has a market cap of £92.33 billion and reported earnings per share of GBX 176.76 for the last quarter.

Market Beat

Jefferies Financial

Tadeu Marroco Purchases 36 Shares of British American Tobacco (LON:BATS) Stock

British American Tobacco's CEO, Tadeu Marroco, has acquired additional shares through incentive schemes, including the Deferred Share Bonus Scheme and the Long-Term Incentive Plan. The shares, valued in the low six-figure pound range, reflect routine remuneration rather than a strategic shift. This aligns executive compensation with shareholder interests. Analysts rate BATS stock as a Buy with a £4900.00 price target, citing solid financial performance despite some challenges. The company focuses on shareholder returns through dividends and long-term incentives.

BAT CEO Tadeu Marroco Receives Additional Shares via Incentive Schemes

British American Tobacco(BTI.US)